AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 290: F741-F751, 2006. First published October 18, 2005; doi:10.1152/ajprenal.00313.2005
0363-6127/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/3/F741    most recent
00313.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in AJP - Renal
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, N.-H.
Right arrow Articles by Gorin, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, N.-H.
Right arrow Articles by Gorin, Y.

Redox dependence of glomerular epithelial cell hypertrophy in response to glucose

Nam-Ho Kim,1,2 Hernan Rincon-Choles,1,3 Basant Bhandari,1 Goutam Ghosh Choudhury,1,2,3,4 Hanna E. Abboud,1,2 and Yves Gorin1

1Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio; 2Department of Medicine, Chonnam National University Hospital, Gwangju, South Korea; and 3Audie L. Murphy Memorial Hospital Division and 4Geriatric Research, Education, and Clinical Center, South Texas Veterans Health Care System, San Antonio, Texas

Podocytes or glomerular epithelial cells (GECs) are important targets of the diabetic microenvironment. Podocyte foot process effacement and widening, loss of GECs and hypertrophy are pathological features of this disease. ANG II and oxidative stress are key mediators of renal hypertrophy in diabetes. The cellular mechanisms responsible for GEC hypertrophy in diabetes are incompletely characterized. We investigated the effect of high glucose on protein synthesis and GEC hypertrophy. Exposure of GECs to high glucose dose dependently stimulated [3H]leucine incorporation, but not [3H]yhymidine incorporation. High glucose resulted in the activation of ERK1/2 and Akt/PKB. ERK1/2 pathway inhibitor or the dominant negative mutant of Akt/PKB inhibited high glucose-induced protein synthesis. High glucose elicited a rapid generation of reactive oxygen species (ROS). The stimulatory effect of high glucose on ROS production, ERK1/2, and Akt/PKB activation was prevented by the antioxidants catalase, diphenylene iodonium, and N-acetylcysteine. Exposure of the cells to hydrogen peroxide mimicked the effects of high glucose. In addition, ANG II resulted in the activation of ERK1/2 and Akt/PKB and GEC hypertrophy. Moreover, high glucose and ANG II exhibited additive effects on ERK1/2 and Akt/PKB activation as well as protein synthesis. These additive responses were abolished by treatment of the cells with the antioxidants. These data demonstrate that high glucose stimulates GEC hypertrophy through a ROS-dependent activation of ERK1/2 and Akt/PKB. Enhanced ROS generation accounts for the additive effects of high glucose and ANG II, suggesting that this signaling cascade contributes to GEC injury in diabetes.

high glucose; angiotensin II; podocytes; reactive oxygen species; protein synthesis; hypertrophy



Address for reprint requests and other correspondence: Y. Gorin, Univ. of Texas Health Science Center, Dept. of Medicine, Div. of Nephrology, MC 7882, 7703 Floyd Curl Dr., San Antonio, TX 78229-3900 (e-mail: gorin{at}uthscsa.edu)


Related articles in AJP - Renal:

Corrigenda

AJP - Renal 2006 291: F254-F255. [Full Text]  



This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
P. G. Tipping
Are Podocytes Passive or Provocative in Proteinuric Glomerular Pathology?
J. Am. Soc. Nephrol., April 1, 2008; 19(4): 651 - 653.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. V. Durvasula and S. J. Shankland
Activation of a local renin angiotensin system in podocytes by glucose
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F830 - F839.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Graham, M. Ding, S. Sours-Brothers, T. Yorio, J.-X. Ma, and R. Ma
Downregulation of TRPC6 protein expression by high glucose, a possible mechanism for the impaired Ca2+ signaling in glomerular mesangial cells in diabetes
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1381 - F1390.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S.-L. Zhang, Y.-W. Chen, S. Tran, I. Chenier, M.-J. Hebert, and J. R. Ingelfinger
Reactive Oxygen Species in the Presence of High Glucose Alter Ureteric Bud Morphogenesis
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2105 - 2115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Chintapalli, S. Yang, D. Opawumi, S. R. Goyal, N. Shamsuddin, A. Malhotra, K. Reiss, and L. G. Meggs
Inhibition of wild-type p66ShcA in mesangial cells prevents glycooxidant-dependent FOXO3a regulation and promotes the survival phenotype
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F523 - F530.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Szabo, A. Biser, R. Benko, E. Bottinger, and K. Susztak
Poly(ADP-Ribose) Polymerase Inhibitors Ameliorate Nephropathy of Type 2 Diabetic Leprdb/db Mice
Diabetes, November 1, 2006; 55(11): 3004 - 3012.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.